Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
复制标题
DOI:
10.1016/j.tvr.2023.200264
复制
发表时间:
2023-12
影响因子:
4.3
通讯作者:
Shuda M
中科院分区:
文献类型:
--
作者:
Khattri M;Amako Y;Gibbs JR;Collura JL;Arora R;Harold A;Li MY;Harms PW;Ezhkova E;Shuda M
Merkel cell polyomavirus (MCV) and high-risk human papillomavirus (HPV) are human tumor viruses that cause Merkel cell carcinoma (MCC) and oropharyngeal squamous cell carcinoma (OSCC), respectively. HPV E7 and MCV large T (LT) oncoproteins target the retinoblastoma tumor suppressor protein (pRb) through the conserved LxCxE motif. We identified enhancer of zeste homolog 2 (EZH2) as a common host oncoprotein activated by both viral oncoproteins through the pRb binding motif. EZH2 is a catalytic subunit of the polycomb 2 (PRC2) complex that trimethylates histone H3 at lysine 27 (H3K27me3). In MCC tissues EZH2 was highly expressed, irrespective of MCV status. Loss-of-function studies revealed that viral HPV E6/E7 and T antigen expression are required for Ezh2 mRNA expression and that EZH2 is essential for HPV(+)OSCC and MCV(+)MCC cell growth. Furthermore, EZH2 protein degraders reduced cell viability efficiently and rapidly in HPV(+)OSCC and MCV(+)MCC cells, whereas EZH2 histone methyltransferase inhibitors did not affect cell proliferation or viability within the same treatment period. These results suggest that a methyltransferase-independent function of EZH2 contributes to tumorigenesis downstream of two viral oncoproteins, and that direct targeting of EZH2 protein expression could be a promising strategy for the inhibition of tumor growth in HPV(+)OSCC and MCV(+)MCC patients.
登录
查看更多内容
DOI:
10.1186/s40463-016-0168-9
发表时间:
2016-10-28
期刊:
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
影响因子:
--
作者:
Idris S;Lindsay C;Kostiuk M;Andrews C;Côté DW;O'Connell DA;Harris J;Seikaly H;Biron VL
通讯作者:
Biron VL
影响因子:
6.2
作者:
Cao, Wei;Feng, Zhien;Chen, Wantao
通讯作者:
Chen, Wantao
DOI:
10.1038/modpathol.2017.8
发表时间:
2017-06
期刊:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
影响因子:
--
作者:
Busam KJ;Pulitzer MP;Coit DC;Arcila M;Leng D;Jungbluth AA;Wiesner T
通讯作者:
Wiesner T
影响因子:
0.8
作者:
Acikalin, Arbil;Bagir, Emine;Paydas, Semra
通讯作者:
Paydas, Semra
DOI:
10.1097/jto.0b013e318298762f
发表时间:
2013-08
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
Hubaux R;Thu KL;Coe BP;MacAulay C;Lam S;Lam WL
通讯作者:
Lam WL